stockrow
Friday 6 November 2026
Export TLRY’s income statement to Excel — free account
Tilray Brands, Inc.
TLRY Healthcare Drug Manufacturers Specialty & Generic
Tilray Brands, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $915.5 million, up 11.5% from fiscal 2025.
- Revenue
- +22.7%
- EPS
- 0.00%
- Free cash flow
- −159.7%
- Total debt
- +43.6%
Quarter to August 2026, against a year earlier
2.81
0.15
−5.07%
Follow TLRY
Alert me
| May '26 | May '25 | May '24 | Dec '23 | May '23 | Dec '22 | May '22 | Dec '21 | May '21 | Dec '20 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | — | — | — | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.67 | 0.44 | 1.69 | 2.32 | 1.65 | 2.79 | 3.44 | 4.91 | 8.87 | 33.47 |
Altman Z-Score |
(1.96) | (5.88) | 0.31 | 7.17 | (0.96) | 7.41 | 0.90 | 7.28 | 1.72 | (0.26) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 47.23 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(3.63) | (11.05) | 2.90 | 1.41 | 0.13 | 4.07 | 3.93 | 3.11 | 3.12 | (2.11) |
Beneish M-Score |
(2.01) | (7.48) | — | — | — | — | — | — | — | — |
P/Operating CF |
(16.45) | (28.29) | 43.53 | (53.35) | 23.67 | 57.59 | (105.28) | (188.98) | 554.85 | (433.58) |
P/B ratio |
0.39 | 0.24 | 0.39 | 0.48 | 0.31 | 0.38 | 0.49 | 0.72 | 1.03 | 31.76 |
Price to Tangible BV |
0.77 | 0.51 | 2.58 | 3.77 | 2.97 | 2.60 | 4.14 | 15.50 | 172.06 | 565.69 |
EV/Sales |
0.83 | 0.51 | 1.83 | 2.66 | 1.83 | 3.05 | 3.71 | 5.53 | 9.72 | 33.90 |
EV/EBITDA |
60.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 212.23 | 0.00 |
EV/Operating CF |
(10.93) | (4.45) | (46.61) | (87.62) | 145.18 | (21.86) | (13.16) | (58.61) | 69.32 | (198.39) |
EV/FCF |
(4.81) | (2.88) | (27.04) | (44.92) | (37.19) | (12.75) | (10.61) | (66.92) | 51.75 | (136.04) |
Quick Ratio |
1.18 | 1.35 | 1.21 | 1.24 | 1.24 | 1.83 | 1.82 | 1.44 | 1.44 | 1.21 |
Current Ratio |
2.21 | 2.46 | 2.27 | 1.79 | 1.79 | 2.87 | 2.87 | 2.20 | 2.20 | 1.91 |
Net Debt/EBITDA |
11.34 | (0.03) | (3.11) | (2.58) | (0.09) | (2.79) | (0.38) | (620.36) | (6.80) | (0.71) |
Debt/Assets |
16.16% | 15.17% | 8.63% | 13.42% | 13.10% | 11.45% | 10.78% | 15.59% | 15.36% | 32.84% |
Debt/Equity |
0.24 | 0.21 | 0.11 | 0.18 | 0.17 | 0.14 | 0.13 | 0.21 | 0.21 | 0.83 |
Asset Turnover |
0.42 | 0.26 | 0.18 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.15 | 0.16 |
Operating CF/Net income |
0.57 | 0.04 | 0.13 | (0.01) | (0.01) | 0.37 | 0.37 | 0.12 | 0.12 | 0.48 |
Capex/Depreciation |
(0.39) | (0.18) | (0.15) | 0.00 | (0.12) | 0.00 | (0.14) | 0.00 | (0.48) | (1.38) |
Interest Coverage |
(2.66) | (76.21) | (4.80) | (11.19) | (100.81) | (39.07) | (21.84) | (46.86) | (4.72) | (5.13) |
| (7.87%) | (88.66%) | (7.25%) | (43.72%) | (37.59%) | (10.79%) | (10.71%) | (8.23%) | (15.19%) | (32.88%) | |
| (5.52%) | (69.46%) | (5.68%) | (33.37%) | (29.78%) | (8.75%) | (8.31%) | (6.10%) | (10.54%) | (20.20%) | |
ROIC |
(2.27%) | (92.17%) | (3.08%) | 0.00% | (24.84%) | 0.00% | (8.27%) | 0.00% | (1.68%) | (25.40%) |
Return on Tangible Assets |
(10.90%) | (223.88%) | (26.15%) | (187.20%) | (188.73%) | (42.42%) | (42.93%) | (31.89%) | (32.43%) | (74.21%) |
Average Days of Receivables |
75.42 | 53.99 | 47.05 | 50.05 | 50.19 | 55.18 | 55.34 | 64.02 | 62.11 | 50.35 |
Research and Development Expense of Revenue |
0.04% | 0.03% | 0.08% | 0.11% | 0.11% | 0.24% | 0.24% | 0.16% | 0.16% | 2.10% |
Selling, General and Administrative Expense of Revenue |
32.25% | 31.71% | 31.25% | 36.83% | 36.82% | 36.50% | 36.39% | 30.34% | 30.34% | 66.77% |
Intangible Assets out of Total Assets |
0.34 | 0.37 | 0.69 | 0.68 | 0.69 | 0.72 | 0.72 | 0.74 | 0.74 | 0.37 |
Share Based Compensation of Revenue |
5.02% | 2.96% | 4.03% | 0.00% | 6.31% | 0.00% | 5.73% | 0.00% | 3.38% | 14.12% |
Graham Net Nets |
0.10 | 0.29 | (0.08) | (0.18) | (0.20) | (0.10) | (0.09) | (0.18) | (0.15) | (0.02) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.05 | 0.00 | 0.00 |
Earnings Yield |
(19.67%) | (567.57%) | (18.33%) | (101.23%) | (138.76%) | (38.18%) | (19.82%) | (27.19%) | (16.54%) | (4.92%) |
Free Cash Flow Yield |
(25.61%) | (40.26%) | (3.99%) | (2.56%) | (2.99%) | (8.55%) | (10.17%) | (1.68%) | 2.12% | (0.74%) |
Revenue per Share |
8.19 | 9.22 | 10.62 | 1.01 | 10.15 | 1.31 | 13.06 | 1.90 | 19.03 | 16.70 |
Operating CF per Share |
(0.62) | (1.06) | (0.42) | 0.01 | 0.13 | (0.37) | (3.68) | (0.17) | (1.66) | (10.26) |
Capex per Share |
(0.26) | (0.29) | (0.28) | 0.00 | (0.27) | 0.00 | (0.45) | 0.00 | (1.20) | (3.33) |
Free Cash Flow per Share |
(0.88) | (1.36) | (0.70) | 0.01 | (0.14) | (0.37) | (4.14) | (0.17) | (2.86) | (13.59) |
Cash per Share |
2.10 | 2.88 | 3.51 | 0.73 | 7.26 | 0.86 | 8.64 | 1.81 | 18.12 | 15.05 |
Shareholders Equity per Share |
14.26 | 16.73 | 46.36 | 5.37 | 53.88 | 9.14 | 92.29 | 16.54 | 165.66 | 29.66 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
14.26 | 16.73 | 46.36 | 5.37 | 53.88 | 9.14 | 92.29 | 16.54 | 165.66 | 29.66 |
Free Cash Flow |
(98.62) | (120.69) | (51.64) | 7.91 | (8.59) | (177.26) | (199.12) | (44.72) | (76.98) | (171.33) |
Working Capital |
433.75 | 408.32 | 378.54 | 340.00 | 340.05 | 524.00 | 523.16 | 483.00 | 482.37 | 165.74 |
Capital Expenditures |
(29.48) | (26.09) | (20.74) | (20.80) | (16.50) | (34.06) | (21.86) | (38.87) | (32.27) | (41.98) |
Net Current Asset Value |
58.99 | 103.87 | (100.78) | (295.00) | (204.29) | (204.00) | (204.82) | (676.00) | (676.44) | (225.03) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.00 | 0.03 | 0.00 | 0.03 | 0.00 | 0.06 | 0.20 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.11 | 0.25 | 0.25 | 0.30 | 0.31 | 0.26 | 0.26 | 0.10 | 0.10 | 0.15 |
Cash ROIC |
(4.47%) | (5.86%) | (1.27%) | 0.18% | (0.20%) | (3.26%) | (3.66%) | (0.76%) | (1.31%) | (19.60%) |
Accounts Receivable Turnover |
5.89 | 7.36 | 8.41 | 7.28 | 6.92 | 6.60 | 6.78 | 5.79 | 8.82 | 5.43 |
Accounts Payable Turnover |
2.37 | 2.43 | 3.61 | 4.38 | 3.70 | 5.54 | 4.75 | 3.14 | 3.38 | 2.85 |
Inventory Turnover |
2.29 | 2.22 | 2.50 | 2.86 | 2.15 | 2.55 | 2.04 | 1.66 | 2.23 | 1.59 |
Average Days of Payables |
177.25 | 147.90 | 156.15 | 45.18 | 144.95 | 40.18 | 112.33 | 49.80 | 199.22 | 34.92 |
Days of Inventory on Hand |
167.84 | 170.25 | 162.68 | 127.89 | 152.45 | 143.26 | 175.19 | 219.79 | 240.05 | 183.94 |
Average Receivables |
155.33 | 111.59 | 93.85 | 86.11 | 90.61 | 95.14 | 92.64 | 88.65 | 58.17 | 38.79 |
Average Payables |
276.71 | 238.64 | 156.48 | 130.84 | 129.84 | 113.22 | 107.72 | 135.41 | 115.29 | 65.09 |
Average Inventory |
286.04 | 261.48 | 226.54 | 200.78 | 223.28 | 245.76 | 250.76 | 256.21 | 175.04 | 116.71 |
Average Assets |
2,201.17 | 3,148.00 | 4,309.83 | 4,352.63 | 4,878.63 | 5,449.85 | 5,737.35 | 6,025.18 | 3,485.66 | 1,341.94 |
Average Common Equity |
1,542.22 | 2,466.38 | 3,379.59 | 3,322.97 | 3,864.47 | 4,420.18 | 4,450.18 | 4,462.16 | 2,419.61 | 824.42 |
Columns are period end dates · fundamentals updated 2 Nov 2026